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The compound 2,3,7,8-tetrachlorodibenzo-
para-dioxin (TCDD, or dioxin)—the most
toxic halogenated aromatic hydrocarbon
(IARC 1997)—is a ubiquitous contaminant
of various industrial and combustion
processes. It is highly lipophilic, is extremely
stable in the environment, and thus bioaccu-
mulates in the food chain (Birnbaum 1994).
In humans, it has a half-life of 7–9 years
(Pirkle et al. 1989). TCDD has been classi-
fied as a known human carcinogen (IARC
1997) and has been shown to disrupt multi-
ple endocrine pathways (Birnbaum 1994,
1995; IARC 1997). Although health con-
cerns of TCDD exposure initially centered on
cancer, there has been growing concern about
the potential developmental consequences to
populations exposed to TCDD and related
chemicals.
Maternal exposure to dioxin has been
associated with increases in fetal loss and
reduction in birth weight in experimental
studies in rodents and monkeys (Allen et al.
1979; Bjerke et al. 1994; Courtney 1976;
McNulty 1984; Murray et al. 1979; Nau et
al. 1986; Umbreit et al. 1987). Frank struc-
tural malformations usually are not observed
in animal studies, although TCDD has been
associated with a developmental syndrome
involving hydronephrosis, cleft palate, and
fetal thymic atrophy in mice (Birnbaum and
Tuomisto 2000). These developmental effects
are noted at doses below those that cause
overt maternal toxicity.
Case studies and anecdotal reports suggest
that maternal dioxin exposure may also affect
human development. For example, fetal
growth retardation has been described in case
reports of offspring of mothers who consumed
rice oil contaminated with polychlorinated
biphenyls (PCBs), dioxins, and dioxin-like
furans during pregnancy in the Yusho
(Yamashita and Hayashi 1985) and Yu-cheng
(Guo et al. 1995) accidents (Kunita et al.
1984; Rogan 1982; Schantz 1996; Schecter et
al. 1996b). Similarly, anecdotal reports of
Vietnamese women residing in areas sprayed
with Agent Orange, which was contaminated
with dioxin, suggest an increase in sponta-
neous abortion (SAB), stillbirths, neural tube
defects, facial clefts, and hydatidiform (molar)
pregnancies. These findings have not been
confirmed in well-controlled studies with
exposure measurements (Constable and Hatch
1985; Le and Johansson 2001).
There are few epidemiologic studies of the
association between maternal exposure to
TCDD and related compounds (e.g., other
dioxins, furans, and dioxin-like PCBs) and
pregnancy outcomes in humans. Women in
the United States who lived near a horse arena
that was sprayed with dioxin-contaminated oil
did not have higher rates of fetal or infant
mortality, intrauterine growth retardation or
lowered birth weight, or birth defects com-
pared with unexposed women; however, expo-
sure classification was based on soil levels
around their homes (Stockbauer et al. 1988).
In Chapayevsk, Russia, a town contaminated
with dioxin from a chemical plant, rates of
SAB, congenital defects, and preterm deliv-
ery, but not low birth weight, were higher
compared with surrounding areas (Revich et
al. 2001). In contrast, in Sweden, east coast
ﬁshermen’s wives, who are known to consume
more fish contaminated with dioxins and
furans, had a higher frequency of infants with
low birth weight than did west coast fisher-
men’s wives, who consumed less contami-
nated ﬁsh (Rylander et al. 1995, 1996, 2000;
Svensson et al. 1991).
A few studies have used biologic measures
of dioxin exposure, but only in populations
with low background exposures. In a Dutch
population-based study of 38 infants, dioxins
and furans were measured in maternal breast
milk and summarized as dioxin toxic equiva-
lents (TEQ). Birth weight and gestational age
did not differ between those with breast milk
TEQ ≤ 28 ppt (lipid adjusted; median = 18
ppt) and those with > 28 ppt (lipid adjusted;
median = 37 ppt) (Pluim et al. 1996). A larger
Dutch study (Patandin et al. 1998) reported
that birth weight was negatively correlated with
cord plasma PCB levels. Analysis of maternal
breast milk revealed that a large proportion of
total TEQ derived from dioxins, but no sepa-
rate correlation between dioxins and birth
weight was provided (Patandin et al. 1998). In
Finland, birth weight of 166 newborns was
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2003.negatively associated with maternal breast milk
TEQ (range, 10.8–40 ppt, lipid adjusted)
(Vartiainen et al. 1998).
In 1976, an explosion at a trichlorophenol
plant near Seveso, Italy, resulted in the highest
TCDD exposure known in human residential
populations (Mocarelli et al. 1988; Needham
et al. 1991). To date, few studies of the repro-
ductive health effects of TCDD exposure in
Seveso have been conducted. Until early 1978,
rates of SAB were signiﬁcantly elevated in the
exposed zones (zones A, B, and R) relative to
the control zone, zone non-ABR (Fara and Del
Corno 1985). Between 1977 and 1983, no
increased risk for birth defects was observed in
births in any of the exposed zones, but the
number of births was small, with low power to
detect an effect (Mastroiacovo et al. 1988).
These studies did not include any biologic
measures of TCDD exposure.
Twenty years after the explosion, we initi-
ated the Seveso Women’s Health Study
(SWHS), a historical cohort study, to deter-
mine whether there was an association
between TCDD exposure and reproductive
health. Serum samples collected soon after the
explosion rendered it possible to quantify
individual TCDD exposure (Mocarelli et al.
1990). Because the half-life of TCDD in
humans is very long (Pirkle et al. 1989), a
preconception exposure of a woman could
result in in utero exposure to her fetus con-
ceived many years later. We examined the
relationship of maternal serum TCDD levels
and risk of adverse pregnancy outcome in
postexplosion pregnancies, including SAB,
congenital anomalies and disorders, lowered
birth weight, and shortened gestational age.
Materials and Methods
Study population. The explosion at the
ICMESA chemical factory near Seveso, Italy,
located approximately 25 km north of Milan,
occurred on 10 July 1976. Up to 30 kg of
TCDD was deposited over an 18 km2 area
(Di Domenico et al. 1980). The area was sub-
sequently divided into exposure zones based
on surface soil TCDD measurements. Zone A
was the most heavily contaminated area, and
zone B was the next heaviest contaminated
area (Mocarelli et al. 1992). As part of a
health assessment, blood samples were col-
lected for clinical chemistry tests from resi-
dents soon after the explosion; the remaining
portion of the serum was stored for future
studies (Mocarelli et al. 1988).
The follow-up study of the women was con-
ducted in 1996–1998, approximately 20 years
after the explosion. Women eligible for the
SWHS were 40 years old or younger in 1976,
had adequate stored sera collected between 1976
and 1980, and had resided in zone A or B at the
time of the explosion. A total of 1,271 women
met these criteria. Seventeen women could not
be contacted, and 33 had died or were too ill to
participate. Of the 1,221 women contacted, 981
(80%) agreed to participate. Informed consent
was obtained from all women before partici-
pation. Of the 981 women in SWHS, 745 re-
ported having been pregnant, with a total of
1,822 pregnancies. Of these, 888 pregnancies in
510 women were completed after the explosion,
including 33 pregnancies conceived before the
explosion. At follow-up, the 510 women who
had a postexplosion pregnancy were younger at
interview (mean ± SD = 39.7 ± 8.0 years) than
the entire cohort (mean ± SD = 40.8 ± 11.7
years) but older than the 236 women who had
not yet had a pregnancy (mean ± SD = 29.2 ±
8.1 years). The women who had a postexplosion
pregnancy at the time of follow-up had lower
serum TCDD levels [median = 46.2 ppt;
interquartile range (IQR) = 24.3–104.0] than
those women who had not been pregnant
(median = 142.5 ppt; IQR = 52.3–304.5).
The analysis of SAB is restricted to the
769 pregnancies (476 women), including 13
multiple births, that did not end in voluntary
abortion (n = 108), ectopic pregnancy (n =
10), or molar pregnancy (n = 1). We describe
congenital anomalies/disorders among those
pregnancies that did not end in SAB (n = 672
pregnancies, 443 women). The analysis of
fetal growth and gestational age is limited to
the 608 singleton postexplosion live births
(414 women). For the fetal growth and gesta-
tional age analyses, we excluded women with
hypertensive disorders of pregnancy (n = 42)
or diabetes (n = 5).
Procedure. Details of the study procedure
are presented elsewhere (Eskenazi et al. 2001).
The data analyzed for the present analysis were
based on information acquired during a
detailed interview by a trained nurse-inter-
viewer, who was blinded to the woman’s serum
TCDD level and zone of residence. The inter-
view gathered information on sociodemo-
graphic characteristics, personal habits, work
history, and detailed gynecologic, menstrual,
pregnancy, and other medical history. We
derived the information used for analyses from
the woman’s report of her pregnancy history.
For each pregnancy, the woman was asked to
indicate the outcome of the pregnancy (single-
ton live birth, multiple birth, SAB, ectopic
pregnancy, molar pregnancy, voluntary abor-
tion, stillbirth, current pregnancy); the date the
pregnancy ended; and the length of pregnancy
(in weeks or months or if unknown, whether it
was full term). For all live births, the woman
was asked the birth weight in grams, the child’s
sex, and whether or not the child had any birth
defects or other congenital or developmental
diseases. Medical records were requested for all
spontaneous and voluntary abortions, although
not all medical records were located and not all
outcomes were conﬁrmed. We did not request
birth certificates to confirm birth weight or
gestational age, because in Italy the certiﬁcates
do not contain this information. Studies have
suggested that maternal report of birth weight
is accurate when compared with medical
records and birth certiﬁcates (Selevan 1980);
nevertheless, to validate a portion of reports,
we requested all medical records for cesarean
section deliveries and for deliveries occurring at
the central hospital (Hospital of Desio) (n =
139/601 live births = 23%).
Laboratory analyses. For each participant,
we selected the first serum sample collected
between 1976 and 1981 and of adequate vol-
ume (> 0.5 mL) for analysis. Sodium concen-
tration was measured to check for desiccation
before determining individual lipid levels (total
cholesterol and triglycerides). The TCDD con-
centration in these samples, which had been
stored at –20°C at Desio Hospital, Italy, was
measured by high-resolution mass spectrome-
try methods at the U.S. Centers for Disease
Control and Prevention (Patterson et al.
1987). Values were reported on a lipid-weight
basis in parts per trillion (Akins et al. 1989).
TCDD was measured in sera collected in
1976 or 1977 for 413 women (81%), from
1978 through 1981 for 12 women (2%), and
in 1996 for 19 women (4%) whose earlier
samples had become concentrated by desicca-
tion. For women with post-1977 TCDD val-
ues that were detectable but ≤ 10 ppt (n = 6),
the measured value was used. For women with
post-1977 TCDD levels > 10 ppt, the TCDD
exposure level was back-extrapolated to 1976
using the Filser model, a physiologically based
toxicokinetic model (Kreuzer et al. 1997),
for women 16 years old or younger in 1976
(n = 10), and the ﬁrst-order kinetic model for
older women (n = 15) (Pirkle et al. 1989). For
nondetectable values (n = 66, 13%), a serum
TCDD level equal to one-half the detection
limit was assigned (median detection limit =
18.8 ppt) (Hornung and Reed 1990).
Statistical analyses. Statistical analyses were
conducted using STATA 7.0 (Stata 2001). We
analyzed the data to examine all pregnancies
that ended between the explosion in 1976 and
time of interview (1996–1998) and all preg-
nancies occurring within the first 8 years
(1976–1984) or approximately the ﬁrst half-life
after the explosion (Pirkle et al. 1989), when
exposure body burden would be greatest.
Because pregnancy and/or lactation may
affect the TCDD levels in later pregnancies
(Abraham et al. 1996, 1998; Schecter 1998;
Schecter et al. 1996a), we also analyzed the sub-
set of data including only the ﬁrst postexplosion
pregnancies occurring within the two time
frames (1976–1998 and 1976–1984).
The log (base 10) of serum TCDD was
entered as a continuous variable into the regres-
sion equations. A one-unit change in log10
TCDD corresponds to a 10-fold increase in
TCDD itself; therefore, reported regression
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ciated with a 10-fold increase in TCDD. We
used logistic regression to examine the relation
of TCDD to SAB, preterm delivery (< 37
weeks gestation), and small for gestational age
[SGA; deﬁned as less than the 10th percentile
of weight by sex at a given gestational age based
on population statistics for northeast Italy
(Parazzini et al. 1995)]. For these outcomes, we
report the odds ratio (OR) and 95% conﬁdence
intervals (CIs). We examined the relation of
serum TCDD levels to birth weight in grams
and to gestational age in days as continuous end
points using least-squares linear regression
models; we report the coefficient (beta) and
95% conﬁdence intervals (95% CIs). Because
of strong digit preference—namely, reports of
birth weight as multiples of 100 g and of gesta-
tional age in whole weeks—we used options in
STATA to yield robust standard errors. For
analyses with multiple pregnancies per woman,
we used “cluster” options in STATA to account
for nonindependence.
We selected potential confounders and
effect modifiers a priori from the literature.
These covariates included maternal age at
pregnancy, education at interview, maternal
smoking, maternal alcohol use, previous par-
ity, history of low birth weight, history of
SAB, body mass index (BMI; in kilograms per
square meter), height, maternal weight gain,
gestational age, infant’s sex, and years from
pregnancy to interview. BMI was based on
the height and weight measured at interview.
The values of other covariates at the time of
pregnancy were determined from the inter-
view histories. Covariates that confounded
the relationship of TCDD levels and the
outcome in bivariate analyses (defined as a
> 10% change in the coefﬁcient for TCDD)
were entered into a multivariate model and
tested by likelihood ratio. For continuous
outcomes, we also included an interaction
term for TCDD and sex.
If TCDD affected the pregnancy outcome,
the relevant body burden might be either the
initial dose (if this produced permanent pertur-
bations of the reproductive system) or the body
burden at the time of the pregnancy. Hence, we
repeated all ﬁnal models with body burden of
TCDD estimated at the time of pregnancy. We
estimated TCDD at the time of pregnancy by
extrapolating from the TCDD level measured
in serum near the explosion to the date of the
pregnancy using the same models described
above (Kreuzer et al. 1997; Pirkle et al. 1989).
Speciﬁcally, for women (n = 73) with pregnan-
cies that occurred before 31 December 1977,
we used the mother’s serum TCDD value at
the time of the explosion. For women (n = 189)
who were 16 years old or younger in 1976, we
used the Filser model to extrapolate from serum
TCDD level near the time of the explosion to
the time of her ﬁrst postexplosion pregnancy
and then used the ﬁrst-order kinetic model for
later pregnancies. For women (n = 248) who
were older than 16 years at the time of explo-
sion, we used exclusively the ﬁrst-order kinetic
model to estimate serum TCDD levels at all
postexplosion pregnancies.
Results
Table 1 presents sociodemographic characteris-
tics, pregnancy-related factors, and TCDD
levels for the 510 women and their 888 post-
explosion pregnancies. The average age for the
women at the time of explosion was 19.1 years
old (SD = 7.9) and at interview was 39.7 years
old (SD = 8.0). Most women (71%) were
nulliparous at the time of explosion. The mean
age at their postexplosion pregnancy was 28.6
years (SD = 5.4). The average length of recall
between interview and pregnancy was 10.7 years
(SD = 6.2). At interview, 23% of women were
overweight and 66.5% had completed only high
school. For the time during the pregnancy, 12%
reported smoking and most reported gaining
10–15 kg.
The median maternal serum TCDD level
at the time of the explosion was 46.6 ppt,
with an interquartile range of 24.3–104.0 ppt
(range, 2.5–9,140 ppt). TCDD levels were
highest for the youngest group of women,
women who were nulliparous at the time of
the explosion, and for women with the short-
est time of recall to their pregnancy.
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Table 1. Selected sociodemographic and pregnancy characteristics by maternal serum TCDD for 510
women representing 888 pregnancies.
Characteristics No. (%) Serum TCDD [ppt; median (IQR)]
Total women 510 (100) 46.6 (24.3–104.0)
Age at explosion (years)
0–10 62 (12.2) 70.4 (33.3–196.0)
11–20 211 (41.4) 49.9 (23.5–102.0)
21–30 180 (35.3) 38.8 (20.9–79.0)
31–40 57 (11.2) 39.9 (28.5–92.7)
Age at interview (years)
20–29 37 ( 7.3) 75.2 (43.7–214.0)
30–39 228 (44.7) 51.3 (24.4–111.5)
≥ 40 245 (48.0) 40.6 (22.9–81.7)
Preexplosion parity*
0 362 (71.0) 52.6 (25.5–120.0)
1 78 (15.3) 37.6 (21.1–72.1)
≥ 2 70 (13.7) 36.5 (27.3–67.9)
Maternal education at interview
< Required 155 (30.4) 40.4 (23.3–86.2)
Required/high school 339 (66.5) 49.9 (25.4–115.0)
University 16 ( 3.1) 39.1 (13.4–181.3)
Maternal BMI (kg/m2) at interview
Underweight (< 19.8) 66 (12.9) 61.2 (33.0–129.0)
Normal (19.8–26.0) 329 (64.5) 45.8 (22.1–74.7)
Overweight (26.1–29.0) 65 (12.8) 42.1 (22.1–74.7)
Obese (> 29.0) 50 ( 9.8) 37.4 (14.0–112.0)
Total pregnancies 888 (100) 46.6 (24.3–104.0)
Age at pregnancy (years)*
< 20 33 ( 3.7) 43.1 (13.2–84.8)
20–24 163 (18.4) 45.6 (21.6–105.0)
25–29 343 (38.6) 53.7 (26.6–104.0)
> 29 349 (39.3) 41.9 (23.2–88.5)
Year of pregnancy*
1976–1984 402 (45.3) 38.4 (21.1–80.9)
1985–1993 360 (40.5) 52.6 (26.2–100.0)
1994–1997 126 (14.2) 53.2 (27.0–135.0)
Years recalled to pregnancy*
< 5 188 (21.2) 53.5 (27.3–119.0)
5–10 235 (26.5) 52.5 (27.6–119.0)
11–15 218 (24.6) 44.8 (22.5–98.3)
> 15 247 (27.8) 37.2 (20.6–72.1)
Infant sexa
Male 317 (52.9) 44.9 (22.5–88.5)
Female 282 (47.1) 59.7 (25.1–122.0)
Smoking status at pregnancy*a
Nonsmoker 530 (88.2) 52.6 (25.1–110.5)
Smoker 71 (11.8) 38.0 (16.3–76.2)
Maternal weight gain (kg)*a
< 10 121 (20.2) 66.2 (35.6–119.0)
10–15 333 (55.6) 45.8 (22.0–92.4)
16–20 96 (16.0) 49.6 (19.5–122.0)
> 20 25 ( 4.2) 47.1 (23.5–92.9)
aLive births only. *ANOVA for log10 TCDD, p < 0.05.
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were 655 (73.8%) singleton live births, 13
(1.5%) multiple births, 97 (10.9%) SABs,
4 (0.4%) stillbirths, 10 (1.1%) ectopic preg-
nancies, 1 (0.1%) molar pregnancy, and 108
(12.2%) voluntary abortions.
SAB. The 97 SABs terminated, on average,
at 9.6 weeks gestation (SD = 4.0 weeks). Wo-
men who were older at the time of pregnancy,
were nulliparous, or had less than the required
schooling were more likely to have had an SAB
(data not shown).
Figure 1A presents the cumulative distribu-
tion of TCDD levels for mothers of SAB cases
and for live births. The distribution of the SAB
cases is slightly shifted to the left, implying
slightly lower levels of TCDD in mothers of
SAB cases than in mothers of live births
(median TCDD = 37.5 ppt and 48.6 ppt, re-
spectively). Table 2 presents the ORs for SAB
and a 10-fold increase in TCDD, both unad-
justed and adjusted for maternal age, educa-
tion, and history of SAB before the explosion.
There was no increase in the OR for SAB for
the 769 pregnancies that occurred between
1976 and 1998 (adjusted OR = 0.8; 95% CI,
0.6–1.2) or among the 343 pregnancies that
occurred within the first half-life of TCDD
(1976–1984) (adjusted OR = 1.0; 95% CI,
0.6–1.6). There also was no association
between TCDD and SAB when the analysis
was limited to the 467 first postexplosion
pregnancies occurring from 1976 to 1998
(adjusted OR = 0.8; 95% CI, 0.5–1.3) or to
the 251 ﬁrst postexplosion pregnancies occur-
ring from 1976 to 1984 (adjusted OR = 0.9;
95% CI, 0.4–1.9). When we restricted these
analyses to the 70 SAB cases that were con-
firmed by medical records, the results were
similar (data not shown). Substitution of
TCDD level extrapolated to the time of the
conception did not appreciably alter any of
these ﬁndings.
In addition to SAB, there were other
adverse pregnancy outcomes reported by moth-
ers. There were 10 ectopic pregnancies (median
TCDD = 51.6 ppt; range, 11.5–1,420.0), four
stillbirths (median TCDD = 34.8 ppt; range,
23.3–3,690.0), one molar pregnancy (median
TCDD = 61.1 ppt), and one neonatal death
due to asphyxia (maternal serum TCDD =
29.9 ppt).
Congenital anomalies or disorders. The
number (n = 46) of any one speciﬁc congenital
anomaly or disorder reported by the mothers is
small and was not analyzed statistically. Figure
1B indicates that the maternal serum TCDD
levels for births with congenital anomalies/dis-
orders were slightly lower than those for births
without (median TCDD = 40.6 ppt and 49.5
ppt, respectively). There was one case of anen-
cephaly and one case of cleft lip in a child who
had toxoplasmosis; both mothers had serum
TCDD levels below the median for the popu-
lation, 19.5 and 29.9 ppt, respectively. There
were also two cases of hypospadias or epispa-
dias; both mothers had serum TCDD levels
slightly above the median for the population,
61.2 and 74.7 ppt, respectively. On the basis of
congenital anomaly registry data from a nearby
area of Italy (ICBDMS 1999), we expected
0.02 cases of anencephaly (observed = 1), 0.33
cases of cleft lip (observed = 1), and 0.26 cases
of hypospadias (observed = 2). A few cases of
congenital/developmental anomalies or disor-
ders were reported by mothers with TCDD
levels > 100 ppt, including sleep apnea (n = 1),
pyloric stenosis (n = 1), von Recklinhausen’s
disease (n = 1), syndactaly (n = 1), histiocytosis
(n = 1), ventricular tachycardia (n = 1),
hypoplasia of the cord (n = 1), and thallassemia
minor (n = 2).
Birth weight, gestational age, and SGA.
Birth weight and gestational age results are
presented for the 608 singleton births (414
women). Mean birth weight was 3,281 g (SD =
480 g), with a low-birth-weight rate (< 2,500 g)
of 5.1%. The mean gestational age was 39.4
weeks (SD = 1.7 weeks), with a preterm deliv-
ery rate of 4.9%. There were 59 (9.7%) SGA
infants. Average birth weights tended to be
lower among infants of women who were
underweight, were nulliparous, or reported less
weight gain during pregnancy (data not
shown). Shortened gestational age was associ-
ated with a woman’s report of less weight gain
during pregnancy.
Table 3 summarizes the crude and adjusted
linear regression results for birth weight and
TCDD. Unadjusted and adjusted results were
similar. A 10-fold increase in the maternal
serum TCDD levels was not associated with a
change in birth weight among all postexplosion
pregnancies (1976–1998) (adjusted beta = –4 g;
95% CI, –68 to 60) or among the ﬁrst postex-
plosion pregnancy (adjusted beta = –34 g; 95%
CI, –99 to 31) after controlling for maternal
age, education, smoking during pregnancy, ges-
tational age, sex of infant, parity, BMI at inter-
view, and history of a low-birth-weight infant
before the explosion. However, there were
stronger, albeit not signiﬁcant, associations of
lowered birth weight with TCDD among preg-
nancies occurring in the ﬁrst half-life of TCDD
(1976–1984; all pregnancies: adjusted beta =
–92 g; 95% CI, –204 to 19; ﬁrst postexplosion
pregnancy: adjusted beta = –89 g; 95% CI,
–203 to 25).
Figure 1C shows that the cumulative distri-
butions of maternal serum TCDD were similar
for SGA and non-SGA infants (median
TCDD = 55.0 ppt and 50.2 ppt, respectively).
After adjusting for parity, history of low birth
weight, maternal height and BMI, age, educa-
tion, and smoking status, a 10-fold increase in
TCDD was associated with a nonsignificant
increase in odds of an SGA infant among all
postexplosion pregnancies (adjusted OR = 1.2;
95% CI, 0.8–1.8) and among the ﬁrst postex-
plosion pregnancy (adjusted OR = 1.5; 95%
CI, 0.9–2.6; Table 3). These associations, like
those for birth weight, were stronger but still
statistically nonsigniﬁcant when we limited the
Children’s Health | Eskenazi et al.
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Figure 1. Cumulative distributions of maternal
serum TCDD levels by (A) SAB, (B) congenital
anomalies/disorders, and (C) SGA status.
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Table 2. Crude and adjusted ORs and 95% CIs for SAB per 10-fold increase in maternal serum TCDD level.
Log10 TCDD [n (%)]
Pregnancies Years No. SAB Crude OR (95% CI) Adjusted OR (95% CI)a
All eligible 1976–1998 769 97 (12.6) 0.8 (0.6–1.1) 0.8 (0.6–1.2)
1976–1984 343 44 (12.8) 1.0 (0.6–1.6) 1.0 (0.6–1.6)
First eligible 1976–1998 467 55 (11.8) 0.8 (0.5–1.3) 0.8 (0.5–1.3)
1976–1984 251 31 (12.4) 0.9 (0.4–1.9) 0.9 (0.4–1.9)
aAdjusted for maternal age, maternal education, and history of SAB.analysis to pregnancies within the ﬁrst half-life
of TCDD (1976–1984; all pregnancies:
adjusted OR = 1.4; 95% CI, 0.6–2.9; first
postexplosion pregnancies: OR = 1.8; 95% CI,
0.7–4.3). The results were similar when esti-
mated TCDD level at the time of the preg-
nancy was substituted for the measured value
near the time of the explosion.
Table 4 presents the relationship of serum
TCDD levels and gestational age and preterm
delivery. Results for crude and adjusted analy-
sis are similar. There is about a 1.0–1.3-day
nonsigniﬁcant decrease in gestational age per
10-fold increase in maternal serum TCDD
and a 20–50% nonsignificant increase in
odds of preterm delivery after controlling for
potential confounders, regardless of the sub-
sample examined. When we substituted
estimated TCDD at the time of the preg-
nancy for measured TCDD, the results were
unchanged.
Discussion
The SWHS of female residents living near
Seveso in 1976 at the time of the explosion did
not ﬁnd profound effects of TCDD on preg-
nancy outcomes, including SAB, congenital
anomalies/disorders, and measures of birth
weight and gestational duration, when TCDD
exposure was determined before conception
from blood collected from mothers soon after
the explosion or extrapolated to the time of the
conception. However, the associations with
serum TCDD levels were somewhat stronger,
albeit nonsigniﬁcant, for lowered birth weight
and the occurrence of SGA infants in pregnan-
cies that ended within the first half-life of
TCDD after the explosion.
Our results differ from those in the literature
that have reported higher rates of SAB and fetal
growth retardation in monkeys and rodents
(Allen et al. 1979; Bjerke et al. 1994; Courtney
1976; McNulty 1984; Murray et al. 1979; Nau
et al. 1986; Umbreit et al. 1987). Our results
also differ from case reports in the Yusho
(Yamashita and Hayashi 1985) and Yu-cheng
populations (Guo et al. 1995), in Vietnamese
residents (Constable and Hatch 1985; Le and
Johansson 2001), and in epidemiologic studies
of populations with background exposure to
dioxin-like chemicals (Patandin et al. 1998;
Rylander et al. 1995; 2000; Svensson et al.
1991; Vartiainen et al. 1998). Only a few stud-
ies have documented the levels and the exact
nature of exposure of the persons studied
(Patandin et al. 1998; Pluim et al. 1996;
Vartiainen et al. 1998). Thus, many of these
populations may have differed in the mixture of
dioxins, furans, and PCBs to which they were
exposed, which could explain differences in
study results. In the Seveso study, we did not
measure levels of other dioxin-like compounds
[polychlorinated dibenzo-p-dioxins, polychlori-
nated dibenzofurans (PCDFs), PCBs], because
the small volumes of the archived serum (aver-
aging 0.6 mL) did not permit the additional
analyses. We presumed that exposure was pre-
dominantly to TCDD, the speciﬁc dioxin-like
toxicant released in the explosion, and that other
compounds were at background levels.
Our study has some important limitations.
We were not able to conﬁrm all the pregnancy
outcomes with medical records, but instead
based our results on maternal report. Rasmussen
et al. (1990) found that women tended to
underreport the presence of birth defects in their
children, but few reported a defect when none
was noted on the medical records. However,
these authors found no false reports for neural
tube defects, hypospadias, and cleft palate, the
defects of greatest concern based on case reports
of TCDD-exposed women (Constable and
Hatch 1985). Other studies have suggested that
women are accurate reporters of their children’s
birth weight (Axelsson and Rylander 1984;
Burns et al. 1987). In birth weights conﬁrmed
by medical records for the subset of SWHS
infants (n = 139) delivered by cesarean section
or at the Hospital of Desio, we found that
women overestimated their infant’s birth weight
by 22 g, although there was no difference in the
median birth weights obtained by report and by
records (range = –510 to 700 g).
We were not able to ascertain the outcomes
of all possible pregnancies. Many women in
Seveso may have chosen to have a voluntary
abortion after the explosion because of concerns
about the risk to their fetus. In fact, almost one-
third of pregnancies ended in voluntary abor-
tion within the ﬁrst year after the explosion, a
rate that fell to an average of 11% thereafter. A
proportion of these pregnancies could have
resulted in an adverse outcome (Susser 1983).
However, the voluntary abortion rate did not
vary by TCDD exposure (data not shown).
Therefore, the high initial rate of voluntary
abortions probably did not bias the study ﬁnd-
ings. Also, we ascertained only clinically recog-
nized SABs and not those losses that occurred
before a woman was aware that she was preg-
nant. If TCDD exposure acted to increase pre-
clinical loss, we would have missed this effect
entirely (Eskenazi et al. 1995; Wilcox et al.
1988), and thus we would have underestimated
the impact of TCDD exposure.
Although we did not observe an association
between TCDD and adverse pregnancy out-
come, it is biologically plausible. Dioxins are
known to cross the placenta and have been
measured in follicular fluid in humans
(Tsutsumi et al. 1998). TCDD accelerates
blastocyst formation and cell number in
mouse, which may be related to the cellular
proliferation associated with cleft palate.
TCDD may exert some of its developmental
effects by modulating the stimulatory effect of
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Table 3. Crude and adjusted β and 95% CIs for birth weight and OR for SGA infants per 10-fold increase in maternal serum TCDD levels (log10 TCDD).
Birth weight (g) SGA
Crude β (g) Adjusted β (g) Crude OR Adjusted OR
Pregnancies Years No. (95% CI) (95% CI)a No. (%) (95% CI) (95% CI)b
All eligible 1976–1998 608 –33 (–108 to 43) –4 (–68 to 60) 59 (9.7) 1.1 (0.7–1.7) 1.2 (0.8–1.8)
1976–1984 275 –96 (–226 to 35) –92 (–204 to 19) 28 (10.2) 1.2 (0.6–2.5) 1.4 (0.6–2.9)
First eligible 1976–1998 414 –58 (–136 to 20) –34 (–99 to 31) 43 (10.4) 1.4 (0.8–2.2) 1.5 (0.9–2.6)
1976–1984 221 –91 (–222 to 40) –89 (–203 to 25) 24 (10.9) 1.5 (0.6–3.3) 1.8 (0.7–4.3)
aAdjusted for gestational age, gestational age squared, sex of infant, parity, history of low-birth-weight infant, maternal height, maternal BMI, maternal age, maternal education, maternal
smoking status at pregnancy. bAdjusted for parity, history of low-birth-weight infant, maternal height, maternal BMI, maternal age, maternal education, maternal smoking status at pregnancy.
Table 4. Crude and adjusted β and 95% CIs for gestational age and ORs for preterm delivery per 10-fold increase in maternal serum TCDD levels (log10 TCDD).
Preterm delivery
Gestational age (days) (< 37 completed weeks)
Crude β (days) Adjusted β (days) Crude OR Adjusted OR
Pregnancies Years No. (95% CI) (95% CI)a No. (%) (95% CI) (95% CI)b
All eligible 1976–1998 608 –1.1 (–2.9 to 0.7) –1.2 (–2.9 to 0.5) 30 (4.9) 1.2 (0.7–2.4) 1.3 (0.7–2.3)
1976–1984 275 –0.7 (–3.0 to 1.7) –1.0 (–3.1 to 1.2) 15 (5.5) 1.1 (0.4–2.8) 1.5 (0.7–3.2)
First eligible 1976–1998 414 –0.9 (–2.7 to 1.0) –1.0 (–2.7 to 0.8) 21 (5.1) 1.2 (0.6–2.4) 1.2 (0.6–2.5)
1976–1984 221 –1.0 (–3.9 to 1.8) –1.3 (–4.0 to 1.3) 13 (5.9) 1.4 (0.5–4.0) 1.5 (0.5–4.8)
aAdjusted for sex of infant, parity, history of low-birth-weight infant, maternal height, maternal BMI, maternal age, maternal education, maternal smoking status at pregnancy. bAdjusted for
parity, history of low-birth-weight infant, maternal height, maternal BMI, maternal age, maternal education, maternal smoking status at pregnancy.
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eight Yu-cheng women exposed to PCBs and
PCDFs, EGF-stimulated receptor autophos-
phorylation was signiﬁcantly decreased, com-
pared with placentas of unexposed women,
and this decrease in turn was correlated with
lower birth weight (Lucier et al. 1990;
Sunahara et al. 1987). The fetal growth retarda-
tion effects of TCDD in experimental animals
(mice) have been hypothesized to be caused by
TCDD-induced production of reactive oxygen
species and DNA damage in fetal and placental
tissues (Hassoun et al. 1997). Most studies are
consistent with the hypothesis that the effects of
TCDD are mediated via binding to the aryl
hydrocarbon (Ah) receptor. The Ah receptor
mechanism may be involved in antiestrogenic
effects that may play a role in the developmental
and reproductive effects of TCDD observed in
animals (Peterson et al. 1993). However, differ-
ences in susceptibility across experimental ani-
mal strains and species make it difficult to
extrapolate to human pregnancy.
Although it is biologically plausible that
maternal exposure to TCDD could have an
impact on the developing fetus, there is some
evidence that the most profound effects on the
fetus may be paternally rather than maternally
(as presented here) mediated. For example,
Mocarelli et al. (1996, 2000) reported in the
Seveso cohort an increased probability of female
births associated with paternal exposure but not
with maternal exposure. In the subset of the
Seveso cohort who participated in SWHS, we
also did not observe a shift in sex ratio associ-
ated with maternal exposure (Table 1). Only a
small proportion of the fathers of the SWHS
pregnancies were likely to have substantial
exposure to TCDD. Mothers reported that at
the time of explosion fewer than 10% of the
fathers were residents of zone A, about a third
were from zone B, and more than half were
from nonexposed areas.
In conclusion, we report the lack of an
association between maternal serum levels of
TCDD and adverse birth outcomes in the
cohort of women exposed to dioxin in Seveso,
Italy. However, associations of TCDD and
lowered birth weight and SGA are somewhat
stronger, albeit nonsigniﬁcant, for those preg-
nancies occurring in the ﬁrst TCDD half-life
(within 8 years) after the explosion. It remains
possible that the effects of TCDD on birth
outcomes are yet to be observed, because the
most heavily exposed women were the
youngest at follow-up and therefore less likely
to have yet had a postexplosion pregnancy
(Eskenazi et al. 2001).
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